Registration of medicines

Registration of medicines in Uzbekistan

Registration of medicines

Registration of medicines

 

Registering a medicinal product in Uzbekistan is not “just submitting documents.” It involves strict requirements for the dossier, testing, wording, timelines, and communication with authorized bodies. A mistake at any stage typically leads to rejections, delays, and additional costs.

VITA CONSULT takes full responsibility for the entire cycle: product assessment, preparation and localization of the registration dossier, arrangement of required studies, support throughout expert reviews, and handling correspondence and responses to comments—through to the final result. You receive a clear action plan, timeline control, and professional support at every step.

What we do

  • consultation and selection of the optimal registration pathway

  • preparation/verification of the registration dossier (CTD, modules, translations, formatting)

  • coordination of laboratory and other required tests (as per regulations)

  • support during expert evaluation and responses to comments

  • changes to the registration dossier (variations)

  • timeline control and regular client reports

CTA
Need registration without delays? Message us—we’ll assess your product and provide a clear action plan.

Ask a question to specialists

NEWS AND STATS

Registration of medicines

The main legislative acts regulating marketing authorization and circulation of medicines are the Law of Uzbekistan "On Medicines and Pharmaceutical Activities", Resolution dated March 23, 2018 No. 213

State Register of Medicines and Medical Devices

Additions to the State Register of medicines and medical devices and medical equipment approved for use in medical practice of the Republic of Uzbekistan No. 26, 2022 2-sq. (07/19/2022).

Uzbekistan recognized the results of registration of medicines from 20 countries

The List of countries and international organizations has been approved, the results of registration of medicines of which will be recognized from November 1, 2018.

(90) 970-65-34